Initiation of sodium‐glucose cotransporter‐2 inhibitors and the risk of infection‐related hospitalisations: A population‐based cohort study

Documenti analoghi

• Cost‐effectiveness of sodium‐glucose cotransporter‐2 inhibitors in the treatment of diabetic nephropathy in Japan
  di: Keiko Maruyama‐Sakurai, et al.
  Pubblicazione: (2024)
• The effect of sodium‐glucose cotransporter‐2 inhibitors on inflammatory biomarkers: A meta‐analysis of randomized controlled trials
  di: Leonardo Buttice, et al.
  Pubblicazione: (2024)
• Sodium‐glucose cotransporter‐2 inhibitors and subtype‐specific dementia risk: A multinational and multiethnic cohort study
  di: Mingyang Sun, et al.
  Pubblicazione: (2025)
• Use of sodium‐glucose cotransporter‐2 inhibitors in France: Analysis of French nationwide health insurance database
  di: Sibylle de Germay, et al.
  Pubblicazione: (2024)
• Association between sodium‐glucose cotransporter 2 inhibitor use and clinical outcomes in patients with type 2 diabetes after urinary tract infection
  di: Hsiao‐Wei Wang, et al.
  Pubblicazione: (2025)